Search

The article discusses the highlights of the second Consensus Conference on the management of patients with digestive neuroendocrine tumors, held in Frascati, Italy from November 1-4, 2006. Fifty-six experts in the field of digestive endocrine tumors from 18 countries attended the conference. It was divided sequentially into five sessions devoted to specific topics on an anatomical basis, such as small intestine, colon and rectum, appendix, metastatic liver, and poorly-differentiated endocrine carcinomas of hindgut and midgut origin.

The article discusses the 14th Annual European Neuro Endocrine Tumors Society (ENETS) Conference held on March 9-10, 2017. It mentions several inspirational talks given by speakers such as Michal Lotem talks about 'Immune System and Cancer' and Jan Dumanski 'Tumor and Tissue Heterogeneity – What Can We Learn from Breast Cancer.' It also mentions the use of Alpha Interferon as a treatment for neuroendocrine tumors.

The article presents information discussed at the European Neuroendocrine Tumor Society (ENETS) Standards of Care Conference held in Palma de Mallorca, Spain from November 29 to December 1, 2007. Medical specialities included in the expertise of attendees involved the management of patients with gastroenteropancreatic neuroendocrine tumors. The working groups focused on specific clinical experiences such as pathology, biochemistry and chemotherapy.

The article focuses on the efforts European Neuroendocrine Tumor Society (ENETS) to create consensus guidelines for diagnosing and treating patients with digestive neuroendocrine tumors, during its conference in Frascati, Italy in November 2005. The event was divided into 8 sessions devoted to specific topics on an anatomical basis including gastric NET, doudenal NET and pancreatic NET. Each discussion had a chairperson responsible for the case presentation and for conducting the general assembly toward consensus.

The article discusses the highlights of the 7th Annual European Neuroendocrine Tumor Society (ENETS) Conference held in Berlin, Germany on March 11-12, 2010. The annual General Assembly meeting of the organization was also held during the conference. The election and swearing in of officers were also conducted, with Philippe Ruszniewski elected as chairperson and Bertram Wiedenmann re-elected as Society treasurer.

The article presents guidelines formulated at the 2007 European Neuroendocrine Tumor Society (ENETS) Standards of Care Conference on the use of radiological examinations for neuroendocrine tumors. Factors that are importance in the choice of imaging methods include primary tumor detection, the evaluation of its local extent and therapy monitoring. Radiologic modalities such as computer tomography, magnetic resonance imaging and ultrasonography are described.

The article introduces a series of reports published in the issue, including one on the second Consensus Conference on the European Neuroendocrine Tumor Society (ENETS) guidelines and an interview with Professor Robert Millar, editor of "ENETS Newsletter."

Presents abstracts presented at the 3rd Annual European Neuroendocrine Tumor Society in Prague, Czech Republic from March 22 to 24, 2006. "The Retrospective Review of the Patients With Neuroendocrine Tumors Treated in General Faculty Hospital in Prague," by H. Honova et al; "Follow-Up of Patients With Carcinoid Tumors," by B. G. Taal et al; "Zollinger-Ellison Syndrome: Epidemiology and Diagnostic Management in Slovakia," by R. Hyrdel et al.

Provides information on the 21st Conference of European Comparative Endocrinologists in Bonn, Germany in August 2002.

This section presents updates on the European Neuroendocrine Tumor Society (ENETS), as of July 2005. It provides information on the deadline for registration of the 3rd Annual ENETS Conference. It highlights a consensus conference on the ENETS Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumors.

The article discusses how the consensus guidelines issued by the European Neuroendocrine Tumor Society for the treatment of rare metastases of digestive neuroendocrine tumors (NET) were established during a conference held in Palma de Mallorca, Spain in November 2008. Three working groups composed of experts were formed to study diagnostic and treatment issues for peritoneal, bone and lung, brain and other rare metastases. Procedures on how the working groups arrived at the consensus guidelines were also discussed.

Provides information on the research publication objectives of the European Neuroendocrine Tumor Society (ENTS). Researchers who took part in the establishment of the ENTS; Aims of the organization; Highlights of topics at the ENTS conference in Budapest, Hungary from March 25 through 27, 2004.